The Client
A top Bio-Pharmaceutical company approached us to identify and profile the Rising Stars KOL in the disease area of ‘Renal Cell Carcinoma’. The primary objective of the identification was to engage the Rising Stars in Advisory Board of the pharmaceutical company.
The Challenge
The identification of rising stars who could emerge as KOLs.
The Client Value
The potential individuals were identified based on our proprietary scoring method which included the years of experience.
The client was benefited with the profile of the raising
stars identified and was able to strategize to use these raising stars for their product launch in the renal cell carcinoma disease category.
The Client
Our client, a major pharmaceutical company based in Europe, wanted us to identify top EU five KOLs in the multiple sclerosis. The primary objective of the identification was to engage the KOLs in pre-clinical, clinical, launched, and mature product strategies
The Challenge
The challenge was to provide a comprehensive list of KOLs covering from non-English speaking countries.
The Client Value
The comprehensive report which covered the various parameters of identification was delivered to the customer well ahead of the deadline provided by the customer.
The Client
The client asked us to identify the KOLs with top positional influencers in the given therapeutic area for brand marketing.
The Challenge
KOLs with inter connections and obtaining other pertinent information about their networking within the KOL ecosystem.
The Client Value
The deliverable was supplemented with in house built interactive network maps to show the connections among the KOLs and their sphere of influence.
The client found it extremely useful and was benefited by reducing the time of network identification and figured out the relationship clusters.
The Client
An USA based pharmaceutical company with worldwide presence with its products already dominating the market, approached us to profile the identified KOLs in the primary myelofibrosis rare disease
The Challenge
Given the track record of E-Merge tech in the rare diseases areas, it was easy decision for the client to award the project to E-Merge tech. A much narrowed search requirement is a challenge to generate a comprehensive list of top KOLs in the rare disease therapeutic category.
The Client Value
Our comprehensive report delivered well within the deadline immensely benefited our client in expanding their product market.
The report unleashed a list of KOLs who are active in
the rare disease therapeutic area which ultimately facilitated our client in reaching out to the space not explored before.
The Client
A leading FMGC and Healthcare Products company wanted us to identify the social media presence of identified KOLs in the given therapeutic area
The Challenge
Social media being very informal space it was challenging to correlate the KOL in that space. The client was looking for a service provider who is quite strong in the knowledge in therapeutic areas, pharmaceutical industry and also has the web mining and web analytical capabilities. The criteria themselves are the qualities of E-Merge tech. The project was awarded for that reason.
The Client Value
The research revealed abundance of data and insightful information. With info graphics, tables of information and matrixes of data, the client discovered the report as interesting facts.
The client has used this report to complement the regular research output of list of KOLS and their profiles.
The Client
The client is a leading medical device company based in United States of America. The area of interest was cardiovascular and skin diseases. The need was generating conference intelligence report.
The Challenge
The challenge was curating information from plethora of conferences for cardiovascular and skin disease therapeutic category, across the globe including conferences from emerging markets and non English speaking countries.
The Client Value
We provided comprehensive report covering various critical data points such as area of interest, target audiences, exhibit registration, symposia sponsorship, discounts available,
sponsorship and available options, attendee list cost and other information.
The report helped the customer identify their potential targets for product launch and development.
The Client
Our client a big bio-pharmaceutical company which approached us with the requirement of providing biographies of the KOLs .
The Challenge
To provide expert biographies of around 4,000 profiles, within given time.
The Client Value
The report with accurate information helped the customer to quicklytarget their prospects and to expedite their product launching process in the non-English speaking Asian countries.
The Client
A well known USA based pharmaceutical business consulting company approached us with the requirement of identification and profiling of nurses across US and EU for a specific ovarian cancer
The Challenge
The focus was much narrowed and identification of relevant nurses and availability of information was a challenge.
The Client Value
The deliverable was completely loaded with highly relevant information of high profile oncology nurses in gyne-oncology area. The specific activity in particular ovarian cancer type helped the customer to channelize their resources and focus on the specific market sector